We are live on ! Find out more
PCMH

Polymer Capital Management (HK) Portfolio holdings

AUM $1.98B
1-Year Est. Return 210.13%
This Fund
S&P 500
This Quarter Est. Return
+18.23%
1 Year Est. Return
+210.13%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$1.16B
AUM Growth
+$454M
Cap. Flow
+$55M
Cap. Flow %
4.75%
Top 10 Hldgs %
62.6%
Holding
204
New
77
Increased
45
Reduced
22
Closed
50

Top Buys

Rank Stock Value
1
NVDA icon
NVIDIA
NVDA
+$33.1M
2
PANW icon
Palo Alto Networks
PANW
+$12.3M
3
MU icon
Micron Technology
MU
+$11.1M
4
IREN icon
Iris Energy
IREN
+$10.8M
5
GIL icon
Gildan
GIL
+$10.1M

Sector Composition

Rank Sector Weight
1 Miscellaneous 47.62%
2 Technology 23.44%
3 Consumer Discretionary 12.13%
4 Healthcare 8.15%
5 Communication Services 2.81%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ALAB icon
201
Astera Labs
ALAB
$50.2B
-8,803
Closed -$1.46M
TTAN
202
ServiceTitan Inc
TTAN
$9.53B
-5,127
Closed -$546K
FIG
203
Figma
FIG
$15.4B
-16,430
Closed -$614K
FRMI
204
Fermi Inc
FRMI
$3.2B
-35,100
Closed -$281K

Similar funds

Polymer Capital Management (HK)'s Q1 2026 Portfolio in Review

As of Q1 2026, Polymer Capital Management (HK) held 204 positions worth $1.16B, up 65% from $703M the previous quarter. Its ten largest holdings account for 63% of the portfolio.

Polymer Capital Management (HK) deployed $55M of net new capital in Q1 2026, opening 77 new positions and adding to 45 existing holdings. Its largest new stake was Palo Alto Networks: 72,921 shares worth $11.7M.

By sector, the portfolio is most concentrated in Miscellaneous at 48% of assets, up from 29% a quarter earlier, followed by Technology and Consumer Discretionary.

On the sell side, the largest reduction was Summit Therapeutics, an estimated $20.8M trimmed.

  • Polymer Capital Management (HK)'s largest Q1 2026 buy was Palo Alto Networks: 72,921 shares worth $11.7M.
  • Polymer Capital Management (HK) added most to NVIDIA in Q1 2026, an estimated $33.1M increase.
  • Polymer Capital Management (HK)'s biggest Q1 2026 reduction was Summit Therapeutics, cutting an estimated $20.8M.
  • Polymer Capital Management (HK) fully exited Global X Artificial Intelligence & Technology ETF in Q1 2026, selling an estimated $17.2M.
  • Polymer Capital Management (HK)'s ten largest holdings make up 63% of its $1.16B portfolio in Q1 2026.
  • Polymer Capital Management (HK) opened 77 new positions and closed 50 in Q1 2026.
  • Polymer Capital Management (HK)'s portfolio value rose 65% quarter-over-quarter to $1.16B.

Based on Polymer Capital Management (HK)'s 13F filing for Q1 2026, filed 14 May 2026.